You searched for "AMM"
Saving sight and changing lives: working with Syrian refugees in Jordan
Two ophthalmologists from the Emory Eye Center share their three-year experience of treating refugees in the camps in Jordan. Jordan currently hosts an estimated 1.4 million Syrian people who have fled the war in their home country. Cataract & Cornea...
Comparing femtosecond laser assisted-DMEK to manual DMEK
Femtosecond laser is as a novel tool for performing precise descemetorhexis in descemet membrane endothelial keratoplasty (DMEK) surgery. In DMEK surgery, the recipient’s Descemet membrane is peeled to allow adherence of the donor DMEK tissue to the recipient’s stroma. Complete...
Risk stratification to reduce intraoperative cataract surgical complications
The authors prospectively collected data on 1135 consecutive patients undergoing cataract surgery. They were risk stratified according to categories – A (no additional risk factors, 0 points), B (vitrectomy, corneal scarring, small pupil less than 3mm, shallow anterior chamber less...BEECS (British Emergency Eye Care Society) Annual Meeting 2025
British Emergency Eye Care SocietyWelcome to BEECSThe Society was founded in 2013 with the aim of bringing together practitioners in the United Kingdom who provide acute ophthalmology services within their institutions. We run an annual scientific meeting open to all...Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.AI breakthrough brings geographic atrophy treatment a step closer
A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.
How many injections in nAMD: ranibizumab vs. aflibercept
Intravitreal anti-VEGF injections make up a large proportion of the workload in ophthalmology clinics. Since the introduction of aflibercept with eight weekly injections there has been an option to use a treatment which may require less treatment, with potential cost...
Macular pigment and dark adaptation in older population with normal maculas
Macular pigment (MP) such as lutein, zeaxanthin and meso-zeaxanthin are highly concentrated in the fovea. They protect the retina from damage of ambient blue light via antioxidant properties. In older eyes with normal healthy retina, macular pigment optical density (MPOD)...Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...WVUK (Women in Vision) Winter Meeting 2023
December 2, 2022, brought together Women in Vision UK (WVUK) members for their winter meeting. WVUK is a membership organisation focussed on gender equality in vision-related sciences and healthcare. This year’s winter meeting was held in Moorfields Education Hub and...
VIBIM Study: One-year results of treatment of DME with aflibercept using TnE
The VIBIM study (the treat-and-extend regimen (TER) using intravitreal aflibercept in diabetic macular edema (DME) study) was designed to evaluate the efficacy of the TER using aflibercept in the management of DME for a period of two years. The authors...
